D2631
Dihexadecyl phosphate
Synonym(s):
DHP, Dicetyl phosphate
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
[CH3(CH2)15O]2P(O)OH
CAS Number:
Molecular Weight:
546.85
UNSPSC Code:
51191904
NACRES:
NA.25
PubChem Substance ID:
EC Number:
218-594-7
Beilstein/REAXYS Number:
1717117
MDL number:
description
anionic
Quality Level
form
powder
mol wt
546.85 g/mol
technique(s)
DNA extraction: suitable
mp
74-75 °C (lit.)
lipid type
phospholipids
storage temp.
−20°C
SMILES string
OP(OCCCCCCCCCCCCCCCC)(OCCCCCCCCCCCCCCCC)=O
InChI
1S/C32H67O4P/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-35-37(33,34)36-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h3-32H2,1-2H3,(H,33,34)
InChI key
RNPXCFINMKSQPQ-UHFFFAOYSA-N
Biochem/physiol Actions
Dihexadecyl phosphate (DHP) is a negatively charged lipid that is used for the formation of model membranes.
Storage Class
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Susruta Samanta et al.
ACS infectious diseases, 4(10), 1519-1528 (2018-07-25)
Understanding molecular properties of outer membrane channels of Gram-negative bacteria is of fundamental significance as they are the entry point of polar antibiotics into bacteria. Outer membrane proteomics revealed OccK8 (OprE) to be among the five most expressed substrate specific
Smita Pawar et al.
Journal of drug targeting, 24(8), 730-743 (2016-02-16)
Efficacy of anticancer drug is limited due to non-selectivity and toxicities allied with the drug; therefore the heart of the present work is to formulate drug delivery systems targeted selectively towards cancer cells with minimal toxicity to normal cells. Targeted
Kenji Suda et al.
Journal of controlled release : official journal of the Controlled Release Society, 266, 301-309 (2017-10-11)
Age-related macular degeneration (AMD), in which choroidal neovascularization (CNV) affects the center of the retina (macula), leads to the irreversible visual loss. The intravitreal injection of anti-angiogenesis antibodies improved the prognosis of AMD, but relatively less invasive therapies should be